Search research articles
Contact Us
Filters
Showing results (161-170 of 180) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma
Howard Colman, Giuseppe Lombardi, Eric T Wong, et al.
Neuro-Oncology
|
October 11, 2017
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)
Dagmar Beier, Martin Proescholdt, Christiane Reinert, et al.
Acta Neuropathologica Communications
|
May 9, 2023
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma
Ayse N Menevse, Laura-Marie Ammer, Arabel Vollmann-Zwerenz, et al.
Acta Neuropathologica Communications
|
September 11, 2023
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages
Lorraine Weidner, Julia Lorenz, Stefanie Quach, et al.
The Lancet. Oncology
|
December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma
Enrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Cancer Letters
|
December 10, 2025
Lactic acid promotes an MDSC-like phenotype via HIF1α stabilization with impact on prognosis in renal cell carcinoma
Nathalie Babl, Florian Voll, Agnieszka Martowicz, et al.
British Journal of Cancer
|
December 26, 2022
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre
Alexander Scheiter, Frederik Hierl, Florian Lüke, et al.
Cancers
|
July 24, 2021
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23
Peter Hau, Didier Frappaz, Elizabeth Hovey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
Ulrich Herrlinger, Niklas Schäfer, Joachim P Steinbach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2022
Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 180) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma
Howard Colman, Giuseppe Lombardi, Eric T Wong, et al.
Neuro-Oncology
|
October 11, 2017
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)
Dagmar Beier, Martin Proescholdt, Christiane Reinert, et al.
Acta Neuropathologica Communications
|
May 9, 2023
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma
Ayse N Menevse, Laura-Marie Ammer, Arabel Vollmann-Zwerenz, et al.
Acta Neuropathologica Communications
|
September 11, 2023
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages
Lorraine Weidner, Julia Lorenz, Stefanie Quach, et al.
The Lancet. Oncology
|
December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma
Enrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Cancer Letters
|
December 10, 2025
Lactic acid promotes an MDSC-like phenotype via HIF1α stabilization with impact on prognosis in renal cell carcinoma
Nathalie Babl, Florian Voll, Agnieszka Martowicz, et al.
British Journal of Cancer
|
December 26, 2022
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre
Alexander Scheiter, Frederik Hierl, Florian Lüke, et al.
Cancers
|
July 24, 2021
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23
Peter Hau, Didier Frappaz, Elizabeth Hovey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
Ulrich Herrlinger, Niklas Schäfer, Joachim P Steinbach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2022
Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Page
of 18